Imagine trying to sleep with a bulky mask and a hose blowing air into your face; that's how most people treat sleep apnea today. This project created a wearable device that clears the airway without any masks or nasal obstructions. It's like switching from a heavy, restrictive brace to a comfortable piece of wearable tech.
Current sleep apnea treatments (PAP devices) are expensive and uncomfortable, leading to an 80% treatment gap and a 35% failure rate in patient compliance.
A connected, non-invasive wearable device that treats sleep apnea without nasal obstruction, validated through clinical trials for safety and efficacy.
If you are a sleep health equipment provider dealing with the 35% of patients who stop using PAP masks due to discomfort — this project developed a wearable device that improves patient compliance by removing nasal obstructions.
If you are a private sleep clinic dealing with an 80% treatment gap where patients cannot access care due to high costs — this project developed an affordable, non-invasive solution that expands access to effective care.
If you are a remote monitoring firm dealing with low adherence to traditional sleep therapies — this project developed a connected, patient-centered device that enhances usability and long-term adherence.
The project aims to address the 80% treatment gap caused by high costs by providing a more affordable and accessible solution compared to current standards.
Based on available project data, the device has undergone clinical validation and design iterations to ensure it is a practical and scalable solution for millions of patients.
Based on available project data, specific patent or licensing details are not provided, though the project was funded via the EIC Accelerator for commercialization.
The device is designed as a non-invasive wearable that replaces the need for PAP masks, simplifying the patient's nightly routine and improving compliance.
The project period ran from 2022-07-01 to 2024-12-31, indicating the development and validation phases are now complete.
The project is led by a single Belgian SME (SUNRISE), representing a 100% industry ratio. This lean structure suggests a fast-track approach to commercialization, focusing entirely on the transition from research to a market-ready medical product without the overhead of academic partners.
Contact SUNRISE in Belgium
Contact us to explore licensing opportunities for this validated sleep apnea technology.
